Welcome to Brain Vector's clinical trial program, where innovation meets opportunity.
We are at the forefront of mental health research, pioneering new approaches to cognitive enhancement and therapy through our cutting-edge VRPME™ (Virtual Reality Positive
Memory Enhancement) technology. As a healthcare professional, you can contribute to groundbreaking studies that aim to transform mental health treatment and improve patient outcomes. Join us on this exciting journey to advance the science of brain health and
make a lasting impact on the field.

How it works

Personalised Brain Health

VRPME™ is an innovative technology, developed by Brain Vector, that leverages the power of our positive emotions to enhance mental health and cognitive performance. This proprietary tool is designed to harness our personal positive memories, creating immersive experiences that promote psychological well-being and brain homeostasis. By stimulating individual positive affects through the recollection of personal memories, VRPME™ aids the brain in achieving its optimal balance, fostering resilience and enhancing mental performance. The approach is highly personalized, crafted to align with each individual's unique life experiences, making it a revolutionary tool for mental health professionals.

VRPME™ is particularly valuable for psychologists and therapists, as it can be integrated into therapeutic practices to potentially prevent mental health issues and improve patient outcomes. The technology is supported by scientific research, including studies that highlight the therapeutic potential of activating positive memories to suppress depression-like behaviors. Brain Vector is committed to making VRPME™ accessible, safe, and effective, setting a new standard in mental health care and cognitive enhancement. By participating in our clinical trials, healthcare professionals can contribute to the evolution of this cutting-edge solution and help unlock the full potential of human mental capabilities.

SCIENCE

VRPME™ Supported by Science

Nature 2015 paper by Pr Ramirez at MIT demonstrates that artificially activating positive memories can suppress depression-like behaviors, highlighting dentate gyrus engram cells as potential therapeutic targets.

Rebecca Alexander's 2021 review explores the role of neurotransmitters, hormones, brain networks, and cognitive functions in positive emotions, as well as the influence of social relationships and environment on these emotions.

Javier Fernandez's study assesses VR's ability to improve memory recall and emotional regulation in people with depression. The results showed VR improved memory recall.

Read more...

Read more...

Read more...

List of Topics for Future VRPME™ Trials

RWE Trial with VRPME™ as a Companion Tool in Psychotherapy
This trial will explore the use of real-world evidence (RWE) to assess the effectiveness of VRPME™ as a supplementary tool in psychotherapy. The focus will be on enhancing therapeutic outcomes by integrating VRPME™ into traditional therapeutic practices, allowing for a more comprehensive understanding of its impact in real-world settings.

VRPME™ for Anhedonia
This trial will investigate the potential of VRPME™ in alleviating anhedonia, a condition characterized by the inability to experience pleasure. By targeting positive memory recall through VR, the study aims to determine whether VRPME™ can effectively improve mood and emotional well-being in individuals experiencing anhedonia.

VRPME™ in Aged Care
This study will focus on the application of VRPME™ in aged care settings, exploring its potential to enhance cognitive function and emotional well-being among the elderly. The trial will assess how VRPME™ can be used to stimulate positive memories and improve the quality of life for older adults.

VRPME™ in Postpartum Depression
This trial will examine the efficacy of VRPME™ in treating postpartum depression. By facilitating the recall of positive autobiographical memories, the study aims to assess whether VRPME™ can serve as an effective intervention for new mothers experiencing depressive symptoms.

VRPME™ in Psychedelic-Assisted Psychotherapy
This innovative trial will explore the integration of VRPME™ with psychedelic-assisted psychotherapy. The study will investigate how VRPME™ can enhance the therapeutic effects of psychedelics by promoting positive emotional states and aiding in the processing of therapeutic experiences.

These trials aim to expand the understanding of VRPME™'s applications across various mental health conditions and settings, contributing to the development of more effective therapeutic interventions.

Be a Part of the VRPME™ Revolution

Are you excited about the potential of VRPME™ and want to be involved in our groundbreaking trials? Or perhaps you’d like to stay in the loop with the latest updates from Brain Vector?

Simply leave your details, and we’ll reach out to you soon.

Join us on this transformative journey!